- call +1-201-465-4211
- email sales@mrinsights.biz
A branded generic is a drug that is bioequivalent to the original product, but is now marketed under another company's brand name. Branded generics are an attractive business for Valeant’s Emerging Markets operations as they enjoy low research and development costs and sustainable sales.
Scope of the Report:
North America accounts for the largest market size of branded generics in 2017 and is projected to lead the market over the forecast period of 2018 to 2025.
The worldwide market for Branded Generics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Branded Generics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Parenteral
Topical
Other
Market Segment by Applications, can be divided into
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
There are 15 Chapters to deeply display the global Branded Generics market.
Chapter 1, to describe Branded Generics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Branded Generics, with sales, revenue, and price of Branded Generics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Branded Generics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Branded Generics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Branded Generics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Branded Generics Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Parenteral
1.2.3 Topical
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiovascular Diseases
1.3.3 Diabetes
1.3.4 Neurology
1.3.5 Gastrointestinal Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan NV
2.1.1 Business Overview
2.1.2 Branded Generics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mylan NV Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Branded Generics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Branded Generics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Branded Generics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sun Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Branded Generics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Aspen Pharmacare Holding
2.6.1 Business Overview
2.6.2 Branded Generics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aspen Pharmacare Holding Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbott Laboratories
2.7.1 Business Overview
2.7.2 Branded Generics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Laboratories Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant Pharmaceuticals International
2.8.1 Business Overview
2.8.2 Branded Generics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals International Branded Generics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Branded Generics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Branded Generics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Branded Generics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Branded Generics Manufacturer Market Share in 2017
3.3.2 Top 6 Branded Generics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Branded Generics Market Analysis by Regions
4.1 Global Branded Generics Sales, Revenue and Market Share by Regions
4.1.1 Global Branded Generics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Branded Generics Revenue and Market Share by Regions (2013-2018)
4.2 North America Branded Generics Sales and Growth Rate (2013-2018)
4.3 Europe Branded Generics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Branded Generics Sales and Growth Rate (2013-2018)
4.5 South America Branded Generics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Branded Generics Sales and Growth Rate (2013-2018)
5 North America Branded Generics by Countries
5.1 North America Branded Generics Sales, Revenue and Market Share by Countries
5.1.1 North America Branded Generics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Branded Generics Revenue and Market Share by Countries (2013-2018)
5.2 United States Branded Generics Sales and Growth Rate (2013-2018)
5.3 Canada Branded Generics Sales and Growth Rate (2013-2018)
5.4 Mexico Branded Generics Sales and Growth Rate (2013-2018)
6 Europe Branded Generics by Countries
6.1 Europe Branded Generics Sales, Revenue and Market Share by Countries
6.1.1 Europe Branded Generics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Branded Generics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Branded Generics Sales and Growth Rate (2013-2018)
6.3 UK Branded Generics Sales and Growth Rate (2013-2018)
6.4 France Branded Generics Sales and Growth Rate (2013-2018)
6.5 Russia Branded Generics Sales and Growth Rate (2013-2018)
6.6 Italy Branded Generics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Branded Generics by Countries
7.1 Asia-Pacific Branded Generics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Branded Generics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Branded Generics Revenue and Market Share by Countries (2013-2018)
7.2 China Branded Generics Sales and Growth Rate (2013-2018)
7.3 Japan Branded Generics Sales and Growth Rate (2013-2018)
7.4 Korea Branded Generics Sales and Growth Rate (2013-2018)
7.5 India Branded Generics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Branded Generics Sales and Growth Rate (2013-2018)
8 South America Branded Generics by Countries
8.1 South America Branded Generics Sales, Revenue and Market Share by Countries
8.1.1 South America Branded Generics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Branded Generics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Branded Generics Sales and Growth Rate (2013-2018)
8.3 Argentina Branded Generics Sales and Growth Rate (2013-2018)
8.4 Colombia Branded Generics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Branded Generics by Countries
9.1 Middle East and Africa Branded Generics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Branded Generics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Branded Generics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Branded Generics Sales and Growth Rate (2013-2018)
9.3 UAE Branded Generics Sales and Growth Rate (2013-2018)
9.4 Egypt Branded Generics Sales and Growth Rate (2013-2018)
9.5 Nigeria Branded Generics Sales and Growth Rate (2013-2018)
9.6 South Africa Branded Generics Sales and Growth Rate (2013-2018)
10 Global Branded Generics Market Segment by Type
10.1 Global Branded Generics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Branded Generics Sales and Market Share by Type (2013-2018)
10.1.2 Global Branded Generics Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Parenteral Sales Growth and Price
10.3.1 Global Parenteral Sales Growth (2013-2018)
10.3.2 Global Parenteral Price (2013-2018)
10.4 Topical Sales Growth and Price
10.4.1 Global Topical Sales Growth (2013-2018)
10.4.2 Global Topical Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Branded Generics Market Segment by Application
11.1 Global Branded Generics Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiovascular Diseases Sales Growth (2013-2018)
11.4 Diabetes Sales Growth (2013-2018)
11.5 Neurology Sales Growth (2013-2018)
11.6 Gastrointestinal Diseases Sales Growth (2013-2018)
12 Branded Generics Market Forecast (2018-2023)
12.1 Global Branded Generics Sales, Revenue and Growth Rate (2018-2023)
12.2 Branded Generics Market Forecast by Regions (2018-2023)
12.2.1 North America Branded Generics Market Forecast (2018-2023)
12.2.2 Europe Branded Generics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Branded Generics Market Forecast (2018-2023)
12.2.4 South America Branded Generics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Branded Generics Market Forecast (2018-2023)
12.3 Branded Generics Market Forecast by Type (2018-2023)
12.3.1 Global Branded Generics Sales Forecast by Type (2018-2023)
12.3.2 Global Branded Generics Market Share Forecast by Type (2018-2023)
12.4 Branded Generics Market Forecast by Application (2018-2023)
12.4.1 Global Branded Generics Sales Forecast by Application (2018-2023)
12.4.2 Global Branded Generics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Branded Generics Picture
Table Product Specifications of Branded Generics
Figure Global Sales Market Share of Branded Generics by Types in 2017
Table Br
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
